1. Home
  2. List
Reference Patent

Reference - List

  • 26 Hits
  • Search Condition : Filter (MeSH = Cholangiocarcinoma / genetics)
Species Resource Title
Human and Animal Cells HuCCT1(RCB1960) Ten-Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild-Type Isocitrate Dehydrogenase 1.
Human and Animal Cells HuCCT1(RCB1960) Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.
Human and Animal Cells HuH-28(RCB1943) , RBE(RCB1292) , SSP-25(RCB1293) Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma.
Human and Animal Cells HuCCT1(RCB1960) FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.
Human and Animal Cells MC3T3-G2/PA6(RCB1127) Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas.
Human and Animal Cells HuCCT1(RCB1960) , RBE(RCB1292) , 293T(RCB2202) BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma.
Human and Animal Cells HuCCT1(RCB1960) Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) , HuH-28(RCB1943) Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.
Human and Animal Cells HuH-28(RCB1943) Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.
Human and Animal Cells SSP-25(RCB1293) , HuH-28(RCB1943) CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis.
Human and Animal Cells HuCCT1(RCB1960) , RBE(RCB1292) Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
Human and Animal Cells TFK-1(RCB2537) Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma.
Human and Animal Cells Hep G2(RCB1886) Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein.
Human and Animal Cells TFK-1(RCB2537) Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
Human and Animal Cells HuCCT1(RCB1960) , TFK-1(RCB2537) Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
Human and Animal Cells SSP-25(RCB1293) , RBE(RCB1292) , TKKK(RCB1907) , HuCCT1(RCB1960) High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.
Human and Animal Cells RBE(RCB1292) , HuCCT1(RCB1960) Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) , TFK-1(RCB2537) Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells.
Human and Animal Cells Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.